Antiretroviral therapy has greatly reduced the incidence of non-Hodgkin lymphoma. But, a new study finds the risk is still high even at low levels of HIV infection.
As the number of patients with HIV who are treated effectively continues to rise, so too will the number of these patients seen for routine primary care. Here, 6 studies to help PCPs offer optimal treatment for this population.
A toddler from Nigeria, whose parents remained there ill with AIDS, presented with a fever and a widespread itchy eruption. Tests for HIV infection were positive. Which systemic etiologies can be ruled out when such an eruption presents?
Asymptomatic neurocognitive impairment is common among HIV-infected patients. Can it be used to predict future cognitive decline? New research answers the question.
A recent study examined the improvement in life expectancy associated with CD4+ cell count response and viral suppression status in patients on combination antiretroviral therapy.
With the advent of powerful antiretroviral therapies, rates of pulmonary malignancy have declined in HIV-infected patients. But, say results of a new study, we can’t take malignant causes out of the differential yet.
The increased risk was independent of potential confounders such as fracture history, alcohol abuse, or use of drugs such as corticosteroids.
A recent trial provides encouraging evidence that vaccination against other infectious diseases may provide protection for persons infected with HIV.
Adherence with antiretroviral therapy among HIV-infected women was as low as 50% at the time the first fixed-combination, single-dose tablet was introduced.
A new study investigates the impact of epidemiologic factors on time trends for AIDS-defining and non–AIDS-defining cancers.